Galmed Pharmaceuticals Ltd. (GLMD) Form 6-K — Sep 2, 2026

Galmed Pharmaceuticals convened its Annual General Meeting of Shareholders on September 2, 2026, but the meeting was adjourned for one day due to lack of quorum. The meeting will be reconvened on Thursday, September 3, 2026 at 4:00 p.m. Israel time at the offices of Meitar Law Offices, the company's legal counsel, at 16 Abba Hillel Silver Rd., Ramat Gan, Israel. The quorum failure is procedural rather than a vote outcome, but it signals low shareholder participation at the micro-cap biotech's meeting.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.